Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Nov;79(11):1193-200.
doi: 10.1111/j.1349-7006.1988.tb01544.x.

A novel B cell line established from Ki-1-positive diffuse large cell lymphoma

Affiliations

A novel B cell line established from Ki-1-positive diffuse large cell lymphoma

H Kamesaki et al. Jpn J Cancer Res. 1988 Nov.

Abstract

A novel cell line, designated KIS-1, was established from a patient with Ki-1-positive diffuse large cell lymphoma. Multiple phenotypic analysis of the KIS-1 cells was carried out with a total of 22 monoclonal antibodies defining hematopoietic cell subsets and lineages. The KIS-1 cells were positive for Ki-1, B4, HLA-DR, and 2D1 (common leucocyte) antigens, but were negative for the antigens reportedly specific for T cells, natural killer cells, granulocytes, monocytes, interdigitating reticulum cells and dendritic reticulum cells. The genomic analysis of the KIS-1 cells showed not only the rearrangement of JH and J kappa genes but also the probable rearrangement of C lambda genes. Moreover, the cells produced immunoglobulin lambda chains. Thus, KIS-1 was considered to be of B-cell lineage. The lymphoma-cell derivation of KIS-1 was based on the following facts. The cytochemical, immunologic, cytogenetic properties and the results of the molecular genomic analysis in the KIS-1 cells were essentially the same as those of the original tumor cells, and the KIS-1 cells were negative for Epstein-Barr virus-associated nuclear antigen. KIS-1 is the only known B-cell line derived from Ki-1-positive diffuse large cell lymphoma, and should be useful for defining the biological implications of Ki-1 antigen.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Schwab , U. , Stein , H. , Gerdes , J. , Lemke , H. , Kirchner , H. , Schaadt , M. and Diehl , V.Production of a monoclonal antibody specific for Hodgkin and Sternberg‐Reed cells of Hodgkin's disease and a subset of normal lymphoid cells . Nature , 299 , 65 – 67 ( 1982. ). - PubMed
    1. ) Stein , H. , Mason , D. Y. , Gerdes , J. , O'Connor , N. , Wainscoat , J. , Pallesen , G. , Gatter , K. , Falini , B. , Delsol , G. , Lemke , H. , Schwarting , R. and Lennert , K.The expression of the Hodgkin's disease associated antigen Ki‐1 in reactive and neoplastic lymphoid tissue: evidence that Reed‐Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells . Blood , 66 , 848 – 858 ( 1985. ). - PubMed
    1. ) Reedman , B. M. and Klein , G.Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and nonproducer lymphoblastoid cell lines . Int. J. Cancer , 11 , 499 – 520 ( 1973. ). - PubMed
    1. ) Fukuhara , S. and Rowley , J. D.Chromosome 14 translocations in non‐Burkitt lymphomas . Int. J. Cancer , 22 , 14 – 21 ( 1978. ). - PubMed
    1. ) Barka , T. and Anderson , P. J.Histochemical method for acid phosphatase using hexazonium pararosaniline as coupler . J. Histochem. Cytochem. , 10 , 741 – 753 ( 1963. ).

Publication types